DBV Technologies | Acreedores Comerciales



Trade Creditors Cambio Fecha
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amarin USD 40.51M 13.88M 2024-09
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
DBV Technologies USD 22.5M 2.68M 2024-09
Halozyme Therapeutics USD 20.07M 9.82M 2025-03
Incyte USD 195.54M 1.93M 2025-03
Insmed USD 77.21M 8.54M 2024-12
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
PTC Therapeutics USD 15.15M 2.12M 2025-03
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
United Therapeutics 6M 357.9M 2024-12



DBV Technologies Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.